181 related articles for article (PubMed ID: 37006620)
1. G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters.
Roy SS; Sharma S; Rizvi ZA; Sinha D; Gupta D; Rophina M; Sehgal P; Sadhu S; Tripathy MR; Samal S; Maiti S; Scaria V; Sivasubbu S; Awasthi A; Harshan KH; Jain S; Chowdhury S
Front Mol Biosci; 2023; 10():1133123. PubMed ID: 37006620
[TBL] [Abstract][Full Text] [Related]
2. RNA G-quadruplex formed in SARS-CoV-2 used for COVID-19 treatment in animal models.
Qin G; Zhao C; Liu Y; Zhang C; Yang G; Yang J; Wang Z; Wang C; Tu C; Guo Z; Ren J; Qu X
Cell Discov; 2022 Sep; 8(1):86. PubMed ID: 36068208
[TBL] [Abstract][Full Text] [Related]
3. G-Quadruplex Targeting in the Fight against Viruses: An Update.
Ruggiero E; Zanin I; Terreri M; Richter SN
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681641
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of RNA G-quadruplexes in the SARS-CoV-2 genome inhibits viral infection via translational suppression.
Razzaq M; Han JH; Ravichandran S; Kim J; Bae JY; Park MS; Kannappan S; Chung WC; Ahn JH; Song MJ; Kim KK
Arch Pharm Res; 2023 Jul; 46(7):598-615. PubMed ID: 37563335
[TBL] [Abstract][Full Text] [Related]
5. The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19.
Panera N; Tozzi AE; Alisi A
Drugs; 2020 Jul; 80(10):941-946. PubMed ID: 32451923
[TBL] [Abstract][Full Text] [Related]
6. The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
Shytaj IL; Fares M; Gallucci L; Lucic B; Tolba MM; Zimmermann L; Adler JM; Xing N; Bushe J; Gruber AD; Ambiel I; Taha Ayoub A; Cortese M; Neufeldt CJ; Stolp B; Sobhy MH; Fathy M; Zhao M; Laketa V; Diaz RS; Sutton RE; Chlanda P; Boulant S; Bartenschlager R; Stanifer ML; Fackler OT; Trimpert J; Savarino A; Lusic M
mBio; 2022 Apr; 13(2):e0370521. PubMed ID: 35229634
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in applying G-quadruplex for SARS-CoV-2 targeting and diagnosis: A review.
Zhai LY; Su AM; Liu JF; Zhao JJ; Xi XG; Hou XM
Int J Biol Macromol; 2022 Nov; 221():1476-1490. PubMed ID: 36130641
[TBL] [Abstract][Full Text] [Related]
8. RNA G-quadruplex forming regions from SARS-2, SARS-1 and MERS coronoviruses.
Kabbara A; Vialet B; Marquevielle J; Bonnafous P; Mackereth CD; Amrane S
Front Chem; 2022; 10():1014663. PubMed ID: 36479439
[TBL] [Abstract][Full Text] [Related]
9. Targeting RNA G-Quadruplex in SARS-CoV-2: A Promising Therapeutic Target for COVID-19?
Zhao C; Qin G; Niu J; Wang Z; Wang C; Ren J; Qu X
Angew Chem Int Ed Engl; 2021 Jan; 60(1):432-438. PubMed ID: 32939952
[TBL] [Abstract][Full Text] [Related]
10. Unlocking G-Quadruplexes as Antiviral Targets.
Abiri A; Lavigne M; Rezaei M; Nikzad S; Zare P; Mergny JL; Rahimi HR
Pharmacol Rev; 2021 Jul; 73(3):897-923. PubMed ID: 34045305
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model.
Chiba S; Kiso M; Nakajima N; Iida S; Maemura T; Kuroda M; Sato Y; Ito M; Okuda M; Yamada S; Iwatsuki-Horimoto K; Watanabe T; Imai M; Armbrust T; Baric RS; Halfmann PJ; Suzuki T; Kawaoka Y
mBio; 2021 Feb; 13(1):e0304421. PubMed ID: 35100870
[TBL] [Abstract][Full Text] [Related]
12. CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands.
Bezzi G; Piga EJ; Binolfi A; Armas P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807682
[TBL] [Abstract][Full Text] [Related]
13. G-Quadruplexes in the Regulation of Viral Gene Expressions and Their Impacts on Controlling Infection.
Zareie AR; Dabral P; Verma SC
Pathogens; 2024 Jan; 13(1):. PubMed ID: 38251367
[TBL] [Abstract][Full Text] [Related]
14. Structurally diverse G-quadruplexes as the noncanonical nucleic acid drug target for live cell imaging and antibacterial study.
Zheng BX; Yu J; Long W; Chan KH; Leung AS; Wong WL
Chem Commun (Camb); 2023 Feb; 59(11):1415-1433. PubMed ID: 36636928
[TBL] [Abstract][Full Text] [Related]
15. Specific binding of G-quadruplex in SARS-CoV-2 RNA by RHAU peptide.
Nguyen LTA; Nguyen TTT; Dang DT
Curr Res Struct Biol; 2024; 7():100126. PubMed ID: 38292819
[TBL] [Abstract][Full Text] [Related]
16. Deciphering RNA G-quadruplex function during the early steps of HIV-1 infection.
Amrane S; Jaubert C; Bedrat A; Rundstadler T; Recordon-Pinson P; Aknin C; Guédin A; De Rache A; Bartolucci L; Diene I; Lemoine F; Gascuel O; Pratviel G; Mergny JL; Andreola ML
Nucleic Acids Res; 2022 Nov; 50(21):12328-12343. PubMed ID: 36453997
[TBL] [Abstract][Full Text] [Related]
17. Targeting G-quadruplexes to achieve antiviral activity.
Ruggiero E; Richter SN
Bioorg Med Chem Lett; 2023 Jan; 79():129085. PubMed ID: 36423824
[TBL] [Abstract][Full Text] [Related]
18. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
[TBL] [Abstract][Full Text] [Related]
19. Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay.
Jang WD; Jeon S; Kim S; Lee SY
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34234012
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review.
Otręba M; Kośmider L; Rzepecka-Stojko A
Eur J Pharmacol; 2020 Nov; 887():173553. PubMed ID: 32949606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
